Endothelial NMMHC IIA Dissociation From PAR1 Activates the CREB3/ARF4 Signaling in Thrombin-Mediated Intracerebral Hemorrhage
November 2024
in “
Journal of Advanced Research
”
Studysummary In this study, the researchers reported that NMMHC IIA dissociates from PAR1 and activates the CREB3/ARF4 pathway, worsening thrombin-induced blood-brain barrier damage, suggesting it as a potential therapeutic target for blood-brain barrier-related diseases. Our plain-language summary of this paper — not a Tressless recommendation.
The study found that the dissociation of NMMHC IIA from PAR1 activates the CREB3/ARF4 signaling pathway, which exacerbates blood-brain barrier (BBB) damage caused by thrombin. This discovery suggests that NMMHC IIA could be a new therapeutic target for treating diseases related to BBB damage.